CompletedPhase 1NCT01951729

The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion

Studying Disorder of carbohydrate metabolism

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Washington University School of Medicine
Principal Investigator
Burton M Wice, PhD
Washington University School of Medicine
Intervention
Control(drug)
Enrollment
15 target
Eligibility
18-65 years · All sexes
Timeline
20132015

Study locations (1)

Collaborators

American Diabetes Association

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01951729 on ClinicalTrials.gov

Other trials for Disorder of carbohydrate metabolism

Additional recruiting or active studies for the same condition.

See all trials for Disorder of carbohydrate metabolism

← Back to all trials